Parthasarathy S, Balaram Hemalatha, Balaram P, Murthy M R N
Molecular Biophysics Unit, Indian Institute of Science, Bangalore 560 012, India.
Acta Crystallogr D Biol Crystallogr. 2002 Dec;58(Pt 12):1992-2000. doi: 10.1107/s0907444902015433. Epub 2002 Nov 23.
The glycolytic enzymes of Plasmodium falciparum (Pf) are attractive drug targets as the parasites lack a functional tricarboxylic cycle and hence depend heavily on glycolysis for their energy requirements. Structural comparisons between Pf triosephosphate isomerase (PfTIM) and its human homologue have highlighted the important differences between the host and parasite enzymes [Velanker et al. (1997), Structure, 5, 751-761]. Structures of various PfTIM-ligand complexes have been determined in order to gain further insight into the mode of inhibitor binding to the parasite enzyme. Structures of two PfTIM-substrate analogue complexes, those of 3-phosphoglycerate (3PG) and glycerol-3-phosphate (G3P), have been determined and refined at 2.4 A resolution. Both complexes crystallized in the monoclinic space group P2(1), with a molecular dimer in the asymmetric unit. The novel aspect of these structures is the adoption of the 'loop-open' conformation, with the catalytic loop (loop 6, residues 166-176) positioned away from the active site; this loop is known to move by about 7 A towards the active site upon inhibitor binding in other TIMs. The loop-open form in the PfTIM complexes appears to be a consequence of the S96F mutation, which is specific to the enzymes from malarial parasites. Structural comparison with the corresponding complexes of Trypanosoma brucei TIM (TrypTIM) shows that extensive steric clashes may be anticipated between Phe96 and Ile172 in the 'closed' conformation of the catalytic loop, preventing loop closure in PfTIM. Ser73 in PfTIM (Ala in all other known TIMs) appears to provide an anchoring water-mediated hydrogen bond to the ligand, compensating for the loss of a stabilizing hydrogen bond from Gly171 NH in the closed-loop liganded TIM structures.
恶性疟原虫(Pf)的糖酵解酶是有吸引力的药物靶点,因为该寄生虫缺乏功能性的三羧酸循环,因此在能量需求上严重依赖糖酵解。Pf磷酸丙糖异构酶(PfTIM)与其人类同源物之间的结构比较突出了宿主酶和寄生虫酶之间的重要差异[韦兰克等人(1997年),《结构》,5,751 - 761]。已确定了各种PfTIM - 配体复合物的结构,以便进一步深入了解抑制剂与寄生虫酶的结合模式。已确定并以2.4埃分辨率精修了两种PfTIM - 底物类似物复合物的结构,即3 - 磷酸甘油酸(3PG)和3 - 磷酸甘油(G3P)的复合物。两种复合物均在单斜空间群P2(1)中结晶,不对称单元中有一个分子二聚体。这些结构的新颖之处在于采用了“环开放”构象,催化环(环6,残基166 - 176)远离活性位点;已知在其他TIMs中,该环在抑制剂结合时会向活性位点移动约7埃。PfTIM复合物中的环开放形式似乎是S96F突变的结果,该突变是疟原虫酶所特有的。与布氏锥虫TIM(TrypTIM)的相应复合物的结构比较表明,在催化环的“闭合”构象中,苯丙氨酸96和异亮氨酸172之间可能会出现广泛的空间冲突,从而阻止PfTIM中的环闭合。PfTIM中的丝氨酸73(在所有其他已知TIMs中为丙氨酸)似乎为配体提供了一个由水介导的锚定氢键,弥补了闭环配体TIM结构中来自甘氨酸171 NH的稳定氢键的损失。